The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Merlin, T.
Right arrow Articles by Freudenberg, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Merlin, T.
Right arrow Articles by Freudenberg, M. A.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
The Journal of Immunology, 2001, 166: 566-573.
Copyright © 2001 by The American Association of Immunologists

Inherited IL-12 Unresponsiveness Contributes to the High LPS Resistance of the Lpsd C57BL/10ScCr Mouse1

Thomas Merlin, Andreas Sing, Peter J. Nielsen, Chris Galanos and Marina A. Freudenberg2

Max Planck Institut für Immunbiologie, Freiburg, Germany


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Lpsd mouse strains are characterized by the presence of a defective Lps/tlr4 gene that make them refractory to the biological activity of LPS. One of the mouse strains commonly used to study LPS defects is the C57BL/10ScCr (Cr) strain. However, unlike other Lpsd strains, the Cr strain also has a heavily impaired IFN-{gamma} response to micro-organisms. As a consequence, unlike other Lpsd mouse strains, they do not acquire a partial LPS susceptibility when treated with sensitizing bacteria. Because IL-12 is important for the microbial induction of IFN-{gamma}, we investigated whether the production or function of IL-12 might be defective in Cr mice. IL-12 mRNA (p35 and p40) was present in the spleen of untreated Cr mice, IL-12p40 mRNA was inducible in mice injected with live or killed Salmonella typhimurium, and IL-12 (p70) was inducible in macrophages by bacteria. Thus, Cr mice exhibit normal IL-12 responses. In functional tests, splenocytes of untreated or of S. typhimurium-infected mice failed to produce IFN-{gamma} when stimulated with murine rIL-12 or with a combination of IL-12 and murine rIL-18 or Con A. Furthermore, Cr mice were identical with IL-12p35/p40 and IL-12 receptor {beta}1 knockout mice in their impaired in vivo and in vitro IFN-{gamma} responses to bacteria. Thus, Cr mice carry a second genetic defect unrelated to the Lps/tlr4 mutation that underlies the IL-12 unresponsiveness and contributes to the LPS resistance and impaired innate immune response in this strain.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The identification of LPS-resistant mouse strains led to the recognition that in mice, sensitivity to LPS is controlled by a gene locus on chromosome 4 called the Lps gene (1). The terms Lpsn and Lpsd were then introduced to designate mice with normal and defective LPS responses, respectively. Lpsd mice are highly resistant to the biological activity of LPS. Today, three LPS-resistant strains with natural mutations in the Lps gene are known, C3H/HeJ (2), C57BL/10ScCr (Cr)3 (3), and its progenitor strain C57BL/10ScN (ScN) (4). In addition, LPS-resistant BALB/c (BALB/c/l) mice were produced independently in two laboratories by backcrossing the defective Lps gene from C3H/HeJ mice into the BALB/c background (5, 6). Recently, the Lps gene was shown to correspond to the Toll-like receptor-4 gene (tlr4) (7) and in the meantime this was confirmed (8). The mutation displayed by C3H/HeJ mice resulted in an exchange of proline for histidine at position 712 of the Tlr4 protein, while the Cr mice carry a null mutation of tlr4 (7). Since then, additional evidence that tlr4 and Lps are identical was obtained by showing that transfection of a number of cell lines with Tlr4 results in the acquisition of LPS susceptibility (9, 10). Furthermore, the disruption of tlr4 by molecular targeting led to an LPS-resistant phenotype of the resulting knockout mice (11).

The LPS susceptibility of mice may increase considerably during infection or after treatment with a variety of killed bacteria, such as Calmette-Guérin bacillus, Propionibacterium acnes, Coxiella burnetii, and Salmonella typhimurium (12, 13, 14, 15, 16). The bacteria-induced sensitization toward LPS is mediated by endogenously produced IFN-{gamma} (13, 17). Upon LPS challenge, sensitized Lpsn mice produce enhanced amounts of proinflammatory cytokines, such as TNF-{alpha}, IL-6, or IFN-{gamma}, and are hypersensitive to the lethal activity of LPS and TNF-{alpha}. Sensitization to LPS proceeds also in the Lpsd C3H/HeJ and BALB/c/l mice, leading to a change of phenotype from LPS resistant to partially LPS sensitive (15, 18, 19). However, a similar sensitization is lacking in Cr mice, which remain LPS resistant after treatment with sensitizing bacteria (20). The absence of sensitization in Cr mice is due to a defect in IFN-{gamma} production in response to bacteria and parasites (13, 20, 21, 22). The impaired IFN-{gamma} production is not due to a general defect in IFN-{gamma} response, because Cr mice are capable of producing IFN-{gamma} when stimulated with the T cell mitogen Con A and CD3 mAbs (20, 21, 22).

Different cell types and soluble factors are involved in the induction of IFN-{gamma}. Thus, in addition to IFN-{gamma}-producing cells (T cells, NK cells, and macrophages) and accessory cells (macrophages and dendritic cells) a number of cytokines are known to participate directly or indirectly in the induction of IFN-{gamma} (22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32). It has been shown that IFN-{beta} is not produced in bacteria-treated Cr mice (22). However, it was recently shown that this lack of IFN-{beta} production is due to their LPS unresponsiveness and cannot explain the IFN-{gamma} defect of Cr mice (33). Furthermore, we demonstrated that the production of IL-1, IL-10, and TNF-{alpha} (33), as well as of IL-2, IL-4, IL-15, IL-18, TGF-{beta}, and the membrane-associated proteins B7-1, B7-2, and CD40 (our unpublished observations), which are all known to be involved in IFN-{gamma} production (34, 35), are normal in Cr mice. Therefore, the IFN-{gamma} defect of Cr mice does not seem to be related to a defective production of one of the above factors.

Among the soluble factors, IL-12 is of special interest, being capable of directly inducing IFN-{gamma} in T and NK cells and promoting T cell differentiation in the IFN-{gamma}-producing Th1 subset (reviewed in Ref. 36). Its IFN-{gamma}-inducing activity can be enhanced further by a synergistic action with accessory cytokines, such as IL-18, or with other stimuli, such as Con A (37). Early in vitro studies showed that bacteria, bacterial products (including LPS), and intracellular parasites were among the most powerful inducers of IL-12 in accessory cells (38, 39). Several in vivo studies have shown that IL-12 is the main factor responsible for the IFN-{gamma} production during various bacterial, parasitic, and viral infections (reviewed in Ref. 40). In the present study it is shown that the IFN-{gamma} defect of Cr mice is caused by their inability to respond to IL-12.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Materials

Bacteria S. typhimurium (C5), Staphylococcus aureus, Listeria monocytogenes, and P. acnes (strain ATCC 12930; American Type Culture Collection, Manassas, VA) were grown and killed as described previously (33). For use, the bacteria were suspended in pyrogen-free PBS, pH 7.2. LPS of Salmonella abortus equi in its uniform triethylamine salt form was obtained as described previously (41). A sterile aqueous stock solution (10 mg/ml) was prepared and stored at 4°C. Before use, the LPS was diluted further with pyrogen-free PBS to the desired concentration. Murine rIL-12 (mrIL-12) was purchased from PharMingen (San Diego, CA), and mrIL-18 was obtained from PANSYSTEMS (Aidenbach, Germany). Con A was purchased from Pharmacia (Freiburg, Germany).

Animals

Lpsn mice, C57BL/10ScSn (Sn), BALB/c, 129 SvPas, IL-12R{beta}1-/- 129 Sv background, and IL-12p35/p40-/- on BALB/c background, and Lpsd mice, Cr and BALB/c/l, were bred under specific pathogen-free conditions in the animal facilities of the Max Planck Institut für Immunbiologie. Breeding pairs of IL-12R{beta}1-/- and IL-12p35/p40-/- were provided by Dr. M. K. Gately (Hoffmann-La Roche, Nutley, NJ), Lpsd ScN breeding pairs were purchased from the Animal Production Program (Frederick Cancer Research and Development Center, Frederick, MD) and bred under conventional clean conditions in the animal facilities of the Max Planck Institute. Five- to 10-wk-old animals of both sexes were used in this study.

P. acnes sensitization and TNF-{alpha} induction

Groups of mice received 625 µg of P. acnes in 0.2 ml of PBS/25 g body weight i.v. Seven days later, the animals received an i.v. injection of LPS (in 0.2 ml of PBS/25 g). One hour after challenge, the animals were exsanguinated under ether anesthesia. The blood was collected in heparinized tubes and centrifuged at 4°C. The resulting plasma was aliquoted and stored at -80°C.

TNF-{alpha} bioassay

TNF-{alpha} in plasma was measured in a cytotoxicity test using a TNF-{alpha}-sensitive L929 cell line in the presence of actinomycin D as described previously (42, 43). The detection limit of the assay was 60 pg of TNF/ml plasma. Rabbit anti-mouse TNF-{alpha} (Genzyme, Boston, MA) was used as an inhibitor to test the specificity of the assay.

Infection

For infection, S. typhimurium (C5), previously passaged through Sn mouse spleens to warrant its virulence, was grown overnight at 37°C on Luria Bertoni agar (Difco, Detroit, MI). Bacteria were suspended in PBS to a concentration of 1500 CFU/ml estimated turbidometrically, and 300 CFU/mouse was administrated i.v. The actual number of CFU in the suspension was determined by plating on Luria Bertoni agar plates and counting the CFU after overnight culture.

Macrophages

Macrophages were derived from bone marrow precursor cells of 5- to 6-wk-old mice after 10 days of culture in the presence of L cell-conditioned medium, as previously described (33). Cells were centrifuged, washed twice, and suspended in a serum-free, high glucose formulation of DMEM at a concentration of 1 x 106/ml. The cells (2 x 105/well) were placed in 96-well plates (Nunc, Roskilde, Denmark) and cultured at 37°C in a humidified atmosphere containing 8% CO2 for 24 h. Thereafter, the macrophage supernatants were replaced by fresh medium, and 10 µl/well of the stimulating agent being tested was added. Cultivation then continued for an additional 24 h. Culture supernatants for IL-12 measurement were collected and stored in aliquots at -80°C.

Splenocytes

Splenocyte suspensions were prepared from spleens of 6- to 8-wk-old mice by pressing spleens through a wire grid. Pooled cells from three or four animals were suspended in serum-free DMEM, adjusted to a concentration of 107/ml, and placed (2 x 106/well) in 96-well plates (Nunc, Roskilde, Denmark). They were then cultured in the presence or the absence of stimulating agents (10 µl/well) at 37°C in a humidified atmosphere containing 8% CO2 for 24 h. Culture supernatants for determination of IFN-{gamma} were stored in aliquots at -80°C until use.

ELISAs

IFN-{gamma} in supernatants of splenocyte cultures and in murine plasma was estimated by a previously described ELISA (44). The limit of IFN-{gamma} detection was 60 pg/ml. IL-12 (p70) in supernatants of macrophage cultures was estimated by ELISA using anti-IL-12 mAb (C17.8) and biotin-labeled anti-IL-12 mAb (C15.6; PharMingen, Hamburg, Germany) as described previously (45). The limit of detection was 15 pg/ml.

RNA extraction

Total RNA was isolated from freshly removed spleens or from cultured splenocytes by a guanidinium isothiocyanate-phenol-chloroform-isoamyl alcohol procedure (46) as described previously (33). The RNA concentration in RNase-free H2O was determined by absorbance at 260 nm.

RT-PCR

Expression of IL-12p35, IL-12p40, and {beta}2-microglobulin mRNA was determined by RT-PCR. One microgram of total RNA was reverse transcribed using the Moloney leukemia virus reverse transcriptase from Life Technologies (Eggenstein, Germany) using random-pd(T)12–18 primers (Pharmacia). The products were appropriately diluted in H2O and used for qualitative PCR analysis, using 34 cycles of amplification in a Biometra (Gottingen, Germany) Thermal Cycler UNO-Thermoblock. RT-PCR primers for IL-12p35 (sense, 5'-GATGACATGGTGAAGACGGCC; antisense, 5'-GGAGGTTTCTGGCGCAGAGT), IL-12p40 (sense, 5'-CTGGCCAGTACACCTGCCAC; antisense, 5'-GTGCTTCCAACGCCAGTTCA), and {beta}2-microglobulin (sense, 5'-TGACCGGCTTGTATGCTATC; antisense, 5'-CAGTGTGAGCCAGGATATAG) were synthesized by BIG-Biotech (Freiburg, Germany). The exon sequences to which all primer pairs anneal contain at least one intron between them, which permits the identification of products derived from contaminating genomic DNA. The annealing temperatures used were 58°C for IL-12p35 and IL-12p40 mRNA and 55°C for {beta}2-microglobulin mRNA detection.

Northern blot analysis

RNA samples (~15 µg) were fractionated on 1.2% denaturing agarose-formaldehyde gel and transferred to Nytran filters as described previously (47). RNAs were hybridized overnight at 65°C with random primed 32P-labeled cDNA probes as described earlier (22). The IFN-{gamma} probe was a 440-bp cDNA fragment of mouse IFN-{gamma} (EcoRI/EcoRV digest of pMugPl plasmid) provided by D. Stüber (Hoffmann-La Roche, Basel, Switzerland). The IL-12p40 probe was an RT-PCR-amplified DNA fragment using the above-described specific primer pairs. The IL-18 probe was a RT-PCR-amplified DNA fragment using specific primers (sense, 5'-ACTGTACAACCGCAGTAATACGG; antisense, 5'-AGTGAACATTACAGATT TATCCC) at a 62°C annealing temperature. The amounts of total RNA applied to the electrophoresis gel for each sample were visualized by the intensity of the ethidium bromide-stained band (18S rRNA) on the Nytran filter (Schleicher & Schuell, Keene, NH) used for hybridization.

RNase protection assay (RPA)

IL-12R{beta}1 and -{beta}2 mRNA were detected by RPA using a RiboQuant MultiProbe RPA system for the detection of cytokine receptors mRNA (PharMingen, San Diego, CA), as described in the provider’s protocol. Briefly, the template set (mCR-3) was used for a T7 RNA polymerase-dependent synthesis of 32P-labeled antisense RNA probes. The RNA samples were hybridized overnight with an excess of labeled probes. After treatment with RNase A and T1 and with proteinase K, the samples were loaded on a 6% polyacrylamide-Tris-borate-EDTA-urea gel and run at 1900 V with 1x Tris-borate-EDTA electrophoresis buffer, pH 8.3. The gel was dried and exposed on film (BIOMAX MS; Eastman Kodak, Rochester, NY) using a cassette with an intensifying screen (Cronex Lightening Plus; DuPont, Wilmington, DE) and kept at -70°C until film development.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Presence of IL-12p35 and IL-12p40 mRNA in the spleen of Cr and Sn mice

IL-12 is a heterodimer of two polypeptide chains, IL-12p35 (p35) and IL-12p40 (p40). The presence of p35 and p40 mRNA in IFN-{gamma}-defective, Cr and IFN-{gamma}-normal, Sn mice was tested for by analysis of the total spleen RNA using RT-PCR. As shown in Fig. 1Go, p35 and p40 mRNA were present in unstimulated splenocytes of both mouse strains. Thus, both IL-12 genes can be transcribed in Cr mice.



View larger version (21K):
[in this window]
[in a new window]
 
FIGURE 1. Expression of IL-12p35 and IL-12p40 mRNA in splenocytes of Sn and Cr mice. Total RNA of splenocytes from Sn and Cr mice was analyzed by RT-PCR for p35 and p40 mRNA expression. Expression of {beta}2-microglobulin ({beta}2m) was used for standardization of RNA amounts. The sizes of the amplified fragments corresponded to the expected sizes (IL-12p35, 402 bp; IL-12p40, 384 bp; {beta}2m, 222 bp). One representative experiment of two is shown. c, control (PCR without cDNA).

 
Inducibility of IL-12p40 mRNA and of IFN-{gamma} by killed S. typhimurium in the spleen of Cr and Sn mice

The detection of mRNA for the highly regulated p40 gene is a good indicator for IL-12 production (40). We investigated the induction of p40 mRNA in the spleen of Cr and Sn mice, stimulated with heat-killed S. typhimurium, by Northern blot analysis. As shown in Fig. 2Goa, only very faint bands of p40 mRNA were detectable in the spleen of unstimulated mice of either mouse strain. Stimulation with bacteria led to a strong induction of p40 mRNA in animals of both strains. The levels were highest at 1 and 2 h of stimulation and decreased 4 h after stimulation (Fig. 2Goa). However, while S. typhimurium-treated mice of both strains exhibited a similar induction of p40 mRNA, only Sn mice exhibited a strong induction of IFN-{gamma} mRNA (Fig. 2Goa). In accordance, circulating IFN-{gamma} was detectable only in Sn, but not in Cr, mice (Fig. 2Gob).



View larger version (42K):
[in this window]
[in a new window]
 
FIGURE 2. Induction of IL-12p40 mRNA and secretion of IFN-{gamma} in Sn and Cr mice injected with S. typhimurium. Sn and Cr mice were injected i.v. with killed S. typhimurium (Stm; 15 µg/g body weight). Untreated mice served as controls (c). a, At different time intervals after treatment the mice were sacrificed, and total spleen RNA was extracted and used for detection of IL-12p40 and IFN-{gamma} mRNA by Northern blot analysis as described in Materials and Methods. For each strain and time point, RNA from two individual animals was analyzed. RNA applied to the gel (~15 µg/lane) was visualized for each sample by the intensity of the ethidium bromide-stained 18S rRNA bands. b, IFN-{gamma} in plasma of mice 6 h after injection of S. typhimurium was measured by a specific ELISA. The data represent mean values of four mice per group ± SD.

 
Inducibility of IL-12p40, IL-18, and IFN-{gamma} transcripts in Lpsn and Lpsd mice by S. typhimurium infection

Induction of p40 mRNA was investigated also in the spleen of Sn and Cr mice, during the first 4 days of infection with S. typhimurium. In addition, induction of mRNAs for IL-18 and IFN-{gamma} was followed in the infected mice. Because S. typhimurium contains LPS, and the two mouse strains, Lpsd Cr and Lpsn Sn, differ in their responsiveness to LPS, the induction of the above cytokines was also investigated in infected Lpsn and Lpsd mice on BALB/c background (BALB/c and BALB/c/l). Control noninfected mice of all four strains used exhibited no IFN-{gamma} mRNA and no, or only a very weak, expression of p40 mRNA in the spleen. However, the mice showed a constitutive expression of IL-18 mRNA in this organ. All mice, especially those of the Lpsd strains, exhibited a detectable induction of p40 mRNA and a significant up-regulation of IL-18 mRNA on day 4 of infection. Interestingly, p40 mRNA bands induced in the spleen of Cr and BALB/c/l mice were always visibly stronger than those in Sn or BALB/c mice, respectively. This finding correlates with the faster progression of S. typhimurium infection observed in Lpsd mice and may be explained by the higher bacterial load present in the spleen of these animals (Table IGo). However, induction of IFN-{gamma} mRNA became detectable on day 2 only in Sn, BALB/c, and BALB/c/l, and increased further on days 3 and 4 of infection (in Fig. 3Go, only expression on day 4 is shown). In Cr mice, IFN-{gamma} mRNA was completely absent on days 2 and 3 (data not shown), and only a weak expression appeared first on day 4 (Fig. 3Go). In agreement, plasma levels of IFN-{gamma} were detectable in infected Sn, BALB/c, and BALB/c/l, but not in infected Cr mice (Table IGo).


View this table:
[in this window]
[in a new window]
 
Table I. Plasma IFN-{gamma} and number of bacteria (CFU) present in the spleens of mice infected with S. typhimurium1

 


View larger version (47K):
[in this window]
[in a new window]
 
FIGURE 3. Expression of IL-12p40, IL-18, and IFN-{gamma} mRNA in the spleen of S. typhimurium-infected Cr mice. Sn, Cr, BALB/c, and BALB/c/l mice were infected i.v. with 3 x 102 CFU of S. typhimurium (Inf.). Untreated mice served as controls (c). Four days after infection, the mice were sacrificed, and total spleen RNA was extracted and used for detection of IL-12p40, IL-18, and IFN-{gamma} mRNA by Northern blot analysis as described in Materials and Methods. RNA from one control and two infected mice per strain was analyzed. RNA was applied to the gel (~15 µg/lane) and visualized for each sample by the intensity of the ethidium bromide-stained 18S ribosomal RNA bands. One representative experiment of two is shown.

 
Production of IL-12 by Lpsn and Lpsd macrophages

To test the capability of Cr mice to produce and secrete IL-12, macrophages of Cr, Sn, BALB/c, and BALB/c/l mice were prepared and stimulated with killed S. typhimurium and S. aureus and with LPS. IL-12 in macrophage supernatants was determined by a specific ELISA for IL-12p70. As shown in Fig. 4Go, unstimulated macrophages of all mouse strains used, including Cr, already exhibited a low constitutive production of IL-12, which increased by a factor of 10 or more upon addition of bacteria to the cultures. Addition of LPS, as expected, induced an IL-12 response only in macrophages of Lpsn Sn and BALB/c, but not of Lpsd Cr and BALB/c/l, mice.



View larger version (54K):
[in this window]
[in a new window]
 
FIGURE 4. Levels of IL-12 in supernatants of Lpsn and Lpsd macrophages stimulated with different agents. Macrophages (106/ml) from Sn, Cr, BALB/c, and BALB/c/l mice were cultured with LPS (0.1 µg/ml), S. typhimurium (Stm; 100 µg/ml), and S. aureus (Sa; 100 µg/ml) for 24 h. IL-12p70 in cell-free supernatants was measured by a specific ELISA. The values are the means of duplicates. One representative experiment of four is shown. *, >=4000 pg/ml.

 
Inability of Cr splenocytes to produce IFN-{gamma} in response to mrIL-12

As shown in the foregoing experiments, Cr mice exhibit a normal production of IL-12 in response to bacteria. In view of the fact that IL-12 is a direct inducer of IFN-{gamma}, we investigated whether the inability of Cr mice to produce IFN-{gamma} when treated with bacteria may be related to IL-12 unresponsiveness. Splenocytes of Cr, Sn, BALB/c, and BALB/c/l mice were stimulated in parallel with different amounts of mrIL-12, and IFN-{gamma} levels in culture supernatants were estimated by ELISA. As shown in Fig. 5Go, IL-12 induced a dose-dependent production of IFN-{gamma} in the Sn, BALB/c, and BALB/c/l cultures, but not in Cr cultures. Furthermore, in Sn splenocytes, the IFN-{gamma} responses to IL-12 were enhanced by addition of rIL-18 or suboptimal (low) amounts of Con A, both of which are known to synergize with IL-12 in the induction of IFN-{gamma} (Fig. 6Go, top). The IFN-{gamma} responses to IL-12 alone or in combination with IL-18 or Con A were still higher when instead of normal splenocytes, splenocytes of S. typhimurium-infected Sn mice were used (Fig. 6Go, bottom). In contrast, in splenocytes of noninfected or infected Cr mice an IFN-{gamma} response to IL-12 alone or to a combination of IL-12 with IL-18 or Con A was absent (Figs. 5Go and 6Go). The IFN-{gamma} response was completely absent even when the amount of IL-12 used in this experiment was increased to 20 ng/ml.



View larger version (22K):
[in this window]
[in a new window]
 
FIGURE 5. IFN-{gamma} response of Lpsn and Lpsd splenocytes to rIL-12. Splenocytes (pooled cells from three animals) of Sn, Cr, BALB/c, and BALB/c/l mice were cultured with different amounts of mrIL-12 for 24 h. IFN-{gamma} in cell-free supernatants was measured by a specific ELISA. Splenocytes cultured in the absence of stimuli produced no detectable IFN-{gamma}. One representative experiment of three is shown.

 


View larger version (37K):
[in this window]
[in a new window]
 
FIGURE 6. IFN-{gamma} response to different stimuli of splenocytes from noninfected and S. typhimurium-infected Sn and Cr mice. Splenocytes (pooled cells from four animals) were obtained from noninfected control Sn and Cr mice, and from mice infected i.v. with 3 x 102 CFU of S. typhimurium (day 4 after infection). The cells were cultured for 24 h with mrIL-12 (4 ng/ml), rIL-18 (10 ng/ml), or Con A (0.5 µg/ml). The agents were applied separately and in combination with IL-12. IFN-{gamma} in cell-free supernatants was measured by a specific ELISA. One representative experiment of three is shown.

 
Cr and knockout mice, lacking endogenous IL-12 activity, exhibit similarly impaired IFN-{gamma} responses

From the above data we assumed that IL-12 unresponsiveness is the most likely reason for the defective IFN-{gamma} response of Cr mice to bacteria. To confirm this, we extended the studies to IL-12R{beta}1-deficient (IL-12R{beta}1-/-) and IL-12p35/p40-/- mice, both lacking endogenous IL-12 activity. A comparison of the IL-12R{beta}1-/-, IL-12p35/p40-/-, and Cr mice revealed that all three types of mice were identical in all respects tested. Splenocytes from all types of mice exhibited no IFN-{gamma} response to killed bacteria (S. typhimurium, S. aureus, P. acnes, and L. monocytogenes in concentrations up to 100 µg/ml). Furthermore, no circulating IFN-{gamma} was detectable in plasma of mice infected with 3 x 102 or 3 x 104 CFU of S. typhimurium (measured up to day 5 after infection; Tables IGo and IIGo). Finally, splenocytes of all three mouse strains exhibited easily detectable IFN-{gamma} responses when stimulated in vitro with high amounts of Con A (5 µg/ml). However, these responses were often 2–3 times lower than the responses obtained in cultures of closely related mice with normal IL-12 activity (data not shown). From these results it is concluded that the inability of Cr mice to produce IFN-{gamma} when stimulated with bacteria is due to IL-12 unresponsiveness.


View this table:
[in this window]
[in a new window]
 
Table II. Plasma IFN-{gamma} and number of bacteria (CFU) present in spleens of S. typhimurium-infected mice lacking endogenous IL-12 activitya

 
Comparison of IL-12 responsiveness between Cr and their progenitor ScN mice

From the above results, it is evident that Cr mice exhibit, in addition to their known LPS response defect, a second phenotypic abnormality, namely IL-12 unresponsiveness. The question arose of whether the two defects were caused by a single mutational event or whether they are based on two independent mutations. For this reason, we compared the ability of mrIL-12 to induce IFN-{gamma} in splenocytes from ScN and Sn mice, which are closely related to Cr mice. The ScN strain is the progenitor to Cr and was shown in the past to also be unresponsive to LPS. Contrary to Lpsn Sn mice, both Lpsd mice, Cr and ScN, fail to express the tlr4 gene (S. N. Vogel and M. A. Freudenberg, unpublished observations). Splenocytes of Cr, ScN, and Sn mice were stimulated in parallel with IL-12 (6.25 ng/ml) for 24 h. Stimulation with Con A (5 µg/ml) was conducted as a positive control. Although splenocytes of Cr mice produced no detectable IFN-{gamma} in response to IL-12, those of ScN and Sn mice produced comparable amounts of this cytokine (Fig. 7Go). Thus, although Cr mice are defective in IL-12 responsiveness, their progenitor ScN, like Sn mice, have normal IL-12 responsiveness. Therefore, it is concluded that the IL-12 unresponsiveness of Cr mice represents a later mutational event that occurred independently of the mutation of tlr4.



View larger version (48K):
[in this window]
[in a new window]
 
FIGURE 7. Differences in the IFN-{gamma} response to rIL-12 by splenocytes of the closely related Cr, ScN, and Sn mice. Splenocytes from ScN, Sn, and Cr mice (pooled cells from four animals) were cultured for 24 h in the presence of rIL-12 (6.25 ng/ml) or Con A (5 µg/ml). IFN-{gamma} in cell-free supernatants was measured by a specific ELISA. Splenocytes cultured in the absence of stimuli produced no detectable IFN-{gamma}. One representative experiment of three is shown.

 
Absence of P. acnes-induced sensitization toward LPS in mice lacking IL-12 activity

Pretreatment of mice with heat-killed P. acnes elicits an IFN-{gamma}-dependent sensitization toward LPS (13, 48). In the following experiments we compared the LPS susceptibility of control and P. acnes-pretreated mice with either a functional (Sn, ScN, 129 SvPas, BALB/c, and BALB/c/l) or a defective (Cr, IL-12p35/p40-/-, and IL-12R{beta}1-/-) IL-12 system. An enhanced TNF-{alpha} response to LPS served as an indicator of sensitization. As shown in Fig. 8Go pretreatment with P. acnes induced a strong sensitization toward LPS in all Lpsn mouse strains with functional IL-12. A sensitization toward LPS was also induced in both P. acnes-treated Lpsd mice belonging to this group, as shown by a partial phenotype change from strictly LPS-nonresponsive to partially LPS-sensitive (Fig. 8Go). In contrast, sensitization was absent in Lpsn IL-12p35/p40-/-, IL-12R{beta}1-/-, and Lpsd Cr mice, showing that sensitization to LPS by P. acnes requires a functional IL-12 system. Thus, independently of the differences in the tlr4 gene, Cr mice share a similar phenotype with IL-12p35/p40-/- and IL-12R{beta}1-/- mice, being resistant to the sensitizing effect of P. acnes.



View larger version (40K):
[in this window]
[in a new window]
 
FIGURE 8. TNF-{alpha} response to LPS of control and P. acnes-sensitized Lpsn and Lpsd mice with a functional or defective IL-12 system. Lpsn and Lpsd mice with a functional IL-12 system (Sn, ScN, 129 SvPas, BALB/c, and BALB/c/l) or defective in IL-12 production (IL-12p35/p40-/-) or IL-12 signaling (Cr and IL-12R{beta}1-/-) received P. acnes (25 µg/g mouse) i.v. or remained untreated. Seven days later all mice received LPS (Lpsn mice, 10 µg/mouse; Lpsd mice, 300 µg/mouse). Plasma for TNF-{alpha} determination was collected 1 h after LPS challenge. The bars represent the mean values of four mice per group ± SD. Differences between the control group and the P. acnes-treated group that are not significant (p > 0.05) are indicated (+).

 
The induction of transcripts of IL-12R chains in Cr mice is normal

The biological activity of IL-12 on cells is mediated via the IL-12R, composed of two subunits, {beta}1 and {beta}2. In this study we compared the inducibility of IL-12{beta}1 and {beta}2 mRNA by Con A in splenocytes of Cr with that of other mouse strains (Sn, BALB/c, and BALB/c/l). As shown in Fig. 9Goa, Con A induced a strong, long-lasting induction of mRNA of both receptor chains in splenocytes of all four mouse strains tested, including Cr. The expression of IL-12R{beta}1 and {beta}2 mRNA in Cr and other mouse strains was also analyzed in the spleen of S. typhimurium-infected animals. As shown in Fig. 9Gob, on day 4 of infection, IL-12{beta}1 and {beta}2 mRNA expression was induced in all mouse strains to a comparable degree. These experiments revealed that both known IL-12R genes are present and normally regulated in Cr mice. The production of functionally normal protein chains remains to be determined and is currently under study.



View larger version (46K):
[in this window]
[in a new window]
 
FIGURE 9. Expression of IL-12R{beta}1 and -{beta}2 mRNA in Lpsn and Lpsd mice. a, Expression in Con A-stimulated splenocytes. Splenocytes (pooled cells from three animals) of Sn, Cr, BALB/c, and BALB/c/l mice were cultured as described in Materials and Methods and stimulated with Con A (5 µg/ml). At different time intervals after stimulation, total RNA was extracted. RNA (2.5 µg) from each sample was used for detection of IL-12R{beta}1 and -{beta}2 mRNA by RPA as described in Materials and Methods. b, Expression in the spleen of S. typhimurium-infected mice. Mice were infected i.v. with 3 x 102 CFU of S. typhimurium (Inf.) or remained untreated (c). Four days after infection spleens of infected and uninfected mice were removed. Total spleen RNA was extracted separately for each animal and pooled for the four identically treated animals of each group. Ten micrograms of each RNA pool was used for detection of IL-12R{beta}1 and -{beta}2 mRNA in an RPA. A constitutive gene probe (GAPDH) was used for standardization of RNA amounts.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
In Cr mice the IFN-{gamma} response to microorganisms is impaired, and this is responsible for the absence of sensitization to LPS in these mice during infection. Because the microbial induction of IFN-{gamma} is predominantly IL-12 dependent, we investigated whether a defect in the production or function of IL-12 may be present in these mice. The present results provide evidence that bacterially induced IL-12 production in Cr mice is intact, being comparable to that of other mouse strains tested, especially to the responses of the Lpsd BALB/c/l mice.

The induction of IFN-{gamma} in resting and activated splenocytes by rIL-12 was used as a measure of the IL-12 responsiveness in these cells. In complete contrast to splenocytes of Sn, BALB/c and BALB/c/l mice, neither splenocytes from healthy nor those from infected Cr mice responded to IL-12 alone or to a combination of IL-12 and IL-18 or Con A. Thus, the impaired IFN-{gamma} response of Cr mice to bacteria and other micro-organisms investigated previously (13, 20, 21, 22) is explained by a lack of IL-12 responsiveness, and this is the underlying reason for the absence of sensitization of these mice to LPS by micro-organisms. The importance of IL-12 for the development of LPS hypersensitivity is evidenced further by the results obtained with IL-12-/- or IL-12R{beta}1-/- knockout mice. These mice are phenotypically similar to Cr mice, exhibiting impaired IFN-{gamma} responses to bacteria and no sensitization to LPS after P. acnes treatment. These results are in accordance with those of an earlier study that demonstrated that IL-12 plays an important role in LPS-induced pathology in Calmette-Guérin bacillus-primed mice (49).

The IL-12 unresponsiveness of Cr mice is not related to their tlr4 gene defect. As shown here, ScN mice, the progenitor strain of Cr, while carrying an identical tlr4 mutation (S. N. Vogel, unpublished observations; A. Poltorak and M. A. Freudenberg, unpublished observations), exhibit intact IL-12 responsiveness, indicating that this second mutation must have occurred after separation of Cr mice from the progenitor colony. As a result, ScN mice exhibit normal IFN-{gamma} responses and, like Lpsd C3H/HeJ and BALB/c/l mice, become partially LPS responding, when pretreated with P. acnes. Further evidence that in Cr mice the defect underlying IL-12 unresponsiveness is not related to the tlr4 mutation was obtained very recently in our laboratory. By intercrossing Cr and Sn mice, there was an independent assortment of the IL-12 unresponsiveness and tlr4 defect in the second filial generation (unpublished observations). Therefore, Cr mice carry two independent mutations, both determining LPS resistance. In addition to the mutation of tlr4, the defect in the IL-12 response exacerbates their LPS resistance. For this reason Cr mice are highly resistant to LPS under conditions (e.g., during infection) during which all other Lpsd mouse strains (C3H/HeJ, BALB/c/l, and ScN) become partially responsive to LPS.

However, it should be noted that Cr mice when treated with exogenous IFN-{gamma} acquire partial LPS sensitivity. This raises the question of how a response to LPS, however low it may be, is possible in the complete absence of Tlr4. Two possibilities arise. One of these has been proposed by Vogel and coworkers, attributing the weak responses of sensitized Lpsd C3H/HeJ mice to bacterial contaminants (LPS-associated protein) present in the LPS preparations (50) that act synergistically with LPS (51). Although such an explanation is plausible, it is still not clear how the synergizing activity of LPS is expressed in Lpsd mice. Another explanation is that LPS may stimulate Lpsd mice via a Tlr4-independent pathway(s), however to a low degree that becomes clearly detectable only after sensitization with IFN-{gamma}. Such a pathway(s) may involve other members of the Tlr protein family, for example Tlr2 (52).

A large amount of information exists on IL-12 recognition and signaling in the mouse (40). We do not know yet whether the IL-12R itself or components of the signal transduction pathway are defective in Cr mice. However, because responses to other cytokines including TNF-{alpha} (53), IFN-{alpha}, IFN-{beta} (22), and IFN-{gamma} (13) are intact in these mice, we assume that the defect concerns a component(s) involved more specifically in the IL-12 response. Components specific for recognition and signaling by IL-12, such as the two {beta} subunits of IL-12R ({beta}1 and {beta}2) (54, 55) or the transcription factor STAT4, have been demonstrated (56). We showed in this study that the induction of transcripts for both IL-12R subunits does not differ from that seen in other IL-12 responder mouse strains investigated. However, this does not prove that functional receptor proteins are expressed on the surface of Cr cells.

In this study the indicator of IL-12 responsiveness in Cr mice was IFN-{gamma} production. In further investigations other activities of IL-12, such as proliferative activity on T cells and NK cell cytotoxicity, should also be addressed. All these activities contribute to the natural resistance to infection. It should be mentioned in this connection that Cr mice were already shown to be highly susceptible to infection with L. major (21), exhibiting a similar nonhealing phenotype as IL-12p40 and p35 knockout mice (57, 58).

Another important factor involved in antibacterial defense is the Lps/tlr4 gene controlling LPS susceptibility, which is defective in BALB/c/l and Cr mice (7, 9, 10, 11). As shown in this study both mouse strains exhibited higher numbers of S. typhimurium in their spleens and were more susceptible to infection than their related Lpsn BALB/c and Sn mice. The high number of bacteria in infected BALB/c/l mice is also a likely explanation for the high levels of IFN-{gamma} appearing in the animals after the third day of infection. A similar observation was made earlier in S. typhimurium-infected Lpsd C3H/HeJ mice (20). Evidently the inability of Lpsd mice to sense LPS abrogates their ability to detect and react against invading Gram-negative bacteria at the early stages of infection.

Because both LPS and IL-12 responsiveness, which are necessary for the integrity of an antimicrobial defense, are impaired in Cr mice, it is postulated that Cr mice are highly sensitive to different pathogens.


    Acknowledgments
 
We thank H. Stübig and N. Goos for excellent technical assistance.


    Footnotes
 
1 This work was supported in part by Bundesministerium für Bildung, Wissenschaft, Forschung, und Technologie-Gesundheit, Projekt O1KI9854/8. Back

2 Address correspondence and reprint requests to Dr. Marina A. Freudenberg, Max Planck Institut für Immunbiologie, Stübeweg 51, D-79108 Freiburg, Germany. Back

3 Abbreviations used in this paper: Cr, C57BL/10ScCr; ScN, C57BL/10ScN; BALB/c/l, LPS-resistant BALB/c; mrIL, murine recombinant IL; Sn, C57BL/10ScSn; RPA, RNase protection assay. Back

Received for publication May 16, 2000. Accepted for publication October 6, 2000.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Vogel, S. N.. 1992. The Lps gene. B. Beutler, ed. Tumor Necrosis Factors: The Molecules and Their Emerging Role in Medicine 485. Raven Press, New York.
  2. Sultzer, B. M.. 1972. Genetic control of host responses to endotoxin. Infect. Immun. 5:107.[Abstract/Free Full Text]
  3. Coutinho, A., T. Meo. 1978. Genetic bases for unresponsiveness to lipopolysaccharide in C57BL/10Cr mice. Immunogenetics 7:17.
  4. Vogel, S. N., C. T. Hansen, D. L. Rosenstreich. 1979. Characterization of a congenitally LPS-resistant, athymic mouse strain. J. Immunol. 122:619.[Abstract/Free Full Text]
  5. Takakuwa, T., H. P. Knopf, A. Sing, R. Carsetti, C. Galanos, M. A. Freudenberg. 1996. Induction of CD14 expression in Lpsn, Lpsd and tumor necrosis factor receptor-deficient mice. Eur. J. Immunol. 26:2686.[Medline]
  6. Vogel, S. N., J. S. Wax, P. Y. Perera, C. Padlan, M. Potter, B. A. Mock. 1994. Construction of a BALB/c congenic mouse, C.C3H-Lpsd, that expresses the Lpsd allele: analysis of chromosome 4 markers surrounding the Lps gene. Infect. Immun. 62:4454.[Abstract/Free Full Text]
  7. Poltorak, A., X. He, I. Smirnova, M. Y. Liu, C. V. Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, et al 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085.[Abstract/Free Full Text]
  8. Qureshi, S. T., L. Lariviere, G. Leveque, S. Clermont, K. J. Moore, P. Gros, D. Malo. 1999. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4): [Published correction appears in 1999 J. Exp. Med. 189:1513.]. J. Exp. Med. 189:615.[Abstract/Free Full Text]
  9. Shimazu, R., S. Akashi, H. Ogata, Y. Nagai, K. Fukudome, K. Miyake, M. Kimoto. 1999. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189:1777.[Abstract/Free Full Text]
  10. Poltorak, A., P. Ricciardi-Castagnoli, S. Citterio, B. Beutler. 2000. Physical contact between lipopolysaccharide and Toll-like receptor 4 revealed by genetic complementation. Proc. Natl. Acad. Sci. USA 97:2163.[Abstract/Free Full Text]
  11. Hoshino, K., O. Takeuchi, T. Kawai, H. Sanjo, T. Ogawa, Y. Takeda, K. Takeda, S. Akira. 1999. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162:3749.[Abstract/Free Full Text]
  12. Abernathy, R. S., G. M. Bradley, W. W. Spink. 1958. Increased susceptibility of mice with brucellosis to bacterial endotoxins. J. Immunol. 81:271.
  13. Katschinski, T., C. Galanos, A. Coumbos, M. A. Freudenberg. 1992. {gamma} interferon mediates Propionibacterium acnes-induced hypersensitivity to lipopolysaccharide in mice. Infect. Immun. 60:1994.[Abstract/Free Full Text]
  14. Matsuura, M., C. Galanos. 1990. Induction of hypersensitivity to endotoxin and tumor necrosis factor by sublethal infection with Salmonella typhimurium. Infect. Immun. 58:935.[Abstract/Free Full Text]
  15. Schramek, S., J. Kazar, Z. Sekeyova, M. A. Freudenberg, C. Galanos. 1984. Induction of hyperreactivity to endotoxin in mice by Coxiella burnetii. Infect. Immun. 45:713.[Abstract/Free Full Text]
  16. Suter, E., G. E. Ullman, R. G. Hoffmann. 1958. Sensibility of mice to endotoxin after vaccination with BCG (bacillus Calmette-Guérin). Proc. Soc. Exp. Biol. Med. 99:167.
  17. Freudenberg, M. A., M. Kopf, C. Galanos. 1996. Lipopolysaccharide-sensitivity of interferon-{gamma}-receptor deficient mice. J. Endotox. Res. 3:291.
  18. Vogel, S. N., R. N. Moore, J. D. Sipe, D. L. Rosenstreich. 1980. BCG-induced enhancement of endotoxin sensitivity in C3H/HeJ mice. I. In vivo studies. J. Immunol. 124:2004.[Abstract]
  19. Freudenberg, M. A., T. Merlin, A. Sing, R. Salomao, C. Galanos. 1999. Bacteria-induced hypersensitivity to endotoxin. H. Brade, and D. C. Morrison, and S. M. Opal, and S. N. Vogel, eds. Endotoxin in Health and Disease 719. Marcel Dekker, New York.
  20. Freudenberg, M. A., Y. Kumazawa, S. Meding, J. Langhorne, C. Galanos. 1991. {gamma} interferon production in endotoxin-responder and -nonresponder mice during infection. Infect. Immun. 59:3484.[Abstract/Free Full Text]
  21. Müller, I., M. Freudenberg, P. Kropf, A. F. Kiderlen, C. Galanos. 1997. Leishmania major infection in C57BL/10 mice differing at the Lps locus: a new non-healing phenotype. Med. Microbiol. Immunol. 186:75.[Medline]
  22. Yaegashi, Y., P. Nielsen, A. Sing, C. Galanos, M. A. Freudenberg. 1995. Interferon {beta}, a cofactor in the interferon {gamma} production induced by Gram-negative bacteria in mice. J. Exp. Med. 181:953.[Abstract/Free Full Text]
  23. Munder, M., M. Mallo, K. Eichmann, M. Modolell. 1998. Murine macrophages secrete interferon {gamma} upon combined stimulation with interleukin (IL)-12 and IL-18: a novel pathway of autocrine macrophage activation. J. Exp. Med. 187:2103.[Abstract/Free Full Text]
  24. Fultz, M. J., S. A. Barber, C. W. Dieffenbach, S. N. Vogel. 1993. Induction of IFN-{gamma} in macrophages by lipopolysaccharide. Int. Immunol. 5:1383.[Abstract/Free Full Text]
  25. Kawase, I., C. G. Brooks, K. Kuribayashi, S. Olabuenaga, W. Newman, S. Gillis, C. S. Henney. 1983. Interleukin 2 induces {gamma}-interferon production: participation of macrophages and NK-like cells. J. Immunol. 131:288.[Abstract]
  26. Le, J., J. X. Lin, D. Henriksen-DeStefano, J. Vilcek. 1986. Bacterial lipopolysaccharide-induced interferon-{gamma} production: roles of interleukin 1 and interleukin 2. J. Immunol. 136:4525.[Abstract]
  27. Wherry, J. C., R. D. Schreiber, E. R. Unanue. 1991. Regulation of {gamma} interferon production by natural killer cells in scid mice: roles of tumor necrosis factor and bacterial stimuli. Infect. Immun. 59:1709.[Abstract/Free Full Text]
  28. Carson, W. E., J. G. Giri, M. J. Lindemann, M. L. Linett, M. Ahdieh, R. Paxton, D. Anderson, J. Eisenmann, K. Grabstein, M. A. Caligiuri. 1994. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J. Exp. Med. 180:1395.[Abstract/Free Full Text]
  29. Trinchieri, G., M. Wysocka, A. D’Andrea, M. Rengaraju, M. Aste-Amezaga, M. Kubin, N. M. Valiante, J. Chehimi. 1992. Natural killer cell stimulatory factor (NKSF) or interleukin-12 is a key regulator of immune response and inflammation. Prog. Growth Factor Res. 4:355.[Medline]
  30. Dinarello, C. A.. 1999. Interleukin-18. Methods 19:121.[Medline]
  31. O’Garra, A., K. Murphy. 1994. Role of cytokines in determining T-lymphocyte function. Curr. Opin. Immunol. 6:458.[Medline]
  32. Bellone, G., M. Aste-Amezaga, G. Trinchieri, U. Rodeck. 1995. Regulation of NK cell functions by TGF-{beta}1. J. Immunol. 155:1066.[Abstract]
  33. Sing, A., T. Merlin, H. P. Knopf, P. J. Nielsen, H. Loppnow, C. Galanos, M. A. Freudenberg. 2000. Bacterial induction of {beta} interferon in mice is a function of the lipopolysaccharide component. Infect. Immun. 68:1600.[Abstract/Free Full Text]
  34. Greenfield, E. A., K. A. Nguyen, V. K. Kuchroo. 1998. CD28/B7 costimulation: a review. Crit. Rev. Immunol. 18:389.[Medline]
  35. van Kooten, C., J. Banchereau. 1997. Functional role of CD40 and its ligand. Int. Arch. Allergy Immunol. 113:393.[Medline]
  36. Adorini, L. 1997. IL-12. In Chemical Immunology, Vol. 68. L. Adorini, K. Arai, C. Berek, J. D. Capra, A.-M. Schmitt-Verhulst, and B. H. Waksman, eds. Karger, Basel, pp. 1–203.
  37. Okamura, H., S. Kashiwamura, H. Tsutsui, T. Yoshimoto, K. Nakanishi. 1998. Regulation of interferon-{gamma} production by IL-12 and IL-18. Curr. Opin. Immunol. 10:259.[Medline]
  38. D’Andrea, A., M. Rengaraju, N. M. Valiante, J. Chehimi, M. Kubin, M. Aste, S. H. Chan, M. Kobayashi, D. Young, E. Nickbarg, et al 1992. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J. Exp. Med. 176:1387.[Abstract/Free Full Text]
  39. D’Andrea, A., X. Ma, M. Aste-Amezaga, C. Paganin, G. Trinchieri. 1995. Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor {alpha} production. J. Exp. Med. 181:537.[Abstract/Free Full Text]
  40. Trinchieri, G.. 1998. Interleukin-12: a cytokine at the interface of inflammation and immunity. Adv. Immunol. 70:83.[Medline]
  41. Galanos, C., O. Luderitz, and O. Westphal. 1979. Preparation and properties of a standardized lipopolysaccharide from Salmonella abortus equi (Novo-Pyrexal). Zentralbl. Bakteriol. Mikrobiol. Hyg. Abt. 1 Orig. 243:226.
  42. Freudenberg, M. A., C. Galanos. 1991. Tumor necrosis factor {alpha} mediates lethal activity of killed Gram-negative and Gram-positive bacteria in D-galactosamine-treated mice. Infect. Immun. 59:2110.[Abstract/Free Full Text]
  43. Aggarwal, B. B., W. J. Kohr, P. E. Hass, B. Moffat, S. A. Spencer, W. J. Henzel, T. S. Bringman, G. E. Nedwin, D. V. Goeddel, R. N. Harkins. 1985. Human tumor necrosis factor: production, purification, and characterization. J. Biol. Chem. 260:2345.[Abstract/Free Full Text]
  44. Slade, S. J., J. Langhorne. 1989. Production of interferon-{gamma} during infection of mice with Plasmodium chabaudi chabaudi. Immunobiology 179:353.[Medline]
  45. Bohn, E., A. Sing, R. Zumbihl, C. Bielfeldt, H. Okamura, M. Kurimoto, J. Heesemann, I. B. Autenrieth. 1998. IL-18 (IFN-{gamma}-inducing factor) regulates early cytokine production in, and promotes resolution of, bacterial infection in mice. J. Immunol. 160:299.[Abstract/Free Full Text]
  46. Chomczynski, P., N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156.[Medline]
  47. Knopf, H. P., F. Otto, R. Engelhardt, M. A. Freudenberg, C. Galanos, F. Herrmann, R. R. Schumann. 1994. Discordant adaptation of human peritoneal macrophages to stimulation by lipopolysaccharide and the synthetic lipid A analogue SDZ MRL 953: down-regulation of TNF-{alpha} and IL-6 is paralleled by an up-regulation of IL-1{beta} and granulocyte colony-stimulating factor expression. J. Immunol. 153:287.[Abstract]
  48. Green, S., A. Dobrjansky, M. A. Chiasson, E. Carswell, M. K. Schwartz, L. J. Old. 1977. Corynebacterium parvum as the priming agent in the production of tumor necrosis factor in the mouse. J. Natl. Cancer Inst. 59:1519.
  49. Wysocka, M., M. Kubin, L. Q. Vieira, L. Ozmen, G. Garotta, P. Scott, G. Trinchieri. 1995. Interleukin-12 is required for interferon-{gamma} production and lethality in lipopolysaccharide-induced shock in mice. Eur. J. Immunol. 25:672.[Medline]
  50. Hogan, M. M., S. N. Vogel. 1988. Production of tumor necrosis factor by rIFN-{gamma}-primed C3H/HeJ (Lpsd) macrophages requires the presence of lipid A-associated proteins. J. Immunol. 141:4196.[Abstract]
  51. Manthey, C. L., P. Y. Perera, B. E. Henricson, T. A. Hamilton, N. Qureshi, S. N. Vogel. 1994. Endotoxin-induced early gene expression in C3H/HeJ (Lpsd) macrophages. J. Immunol. 153:2653.[Abstract]
  52. Yang, R. B., M. R. Mark, A. Gray, A. Huang, M. H. Xie, M. Zhang, A. Goddard, W. I. Wood, A. L. Gurney, P. J. Godowski. 1998. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 395:284.[Medline]
  53. Galanos, C., M. A. Freudenberg, T. Katschinski, R. Salomao, H. Mossmann, and Y. Kumazawa. 1992. Tumor necrosis factor and host response to endotoxin. In Bacterial Endotoxic Lipopolysaccharides, Vol. II: Immunopharmacology and Pathophysiology. J. L. Ryan, and D. C. Morrison, eds. CRC Press, Boca Raton, p. 75.
  54. Presky, D. H., H. Yang, L. J. Minetti, A. O. Chua, N. Nabavi, C. Y. Wu, M. K. Gately, U. Gubler. 1996. A functional interleukin 12 receptor complex is composed of two {beta}-type cytokine receptor subunits. Proc. Natl. Acad. Sci. USA 93:14002.[Abstract/Free Full Text]
  55. Wu, C., J. Ferrante, M. K. Gately, J. Magram. 1997. Characterization of IL-12 receptor {beta}1 chain (IL-12R{beta}1)-deficient mice: IL-12R{beta}1 is an essential component of the functional mouse IL-12 receptor. J. Immunol. 159:1658.[Abstract]
  56. Thierfelder, W. E., J. M. van Deursen, K. Yamamoto, R. A. Tripp, S. R. Sarawar, R. T. Carson, M. Y. Sangster, D. A. Vignali, P. C. Doherty, G. C. Grosveld, et al 1996. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 382:171.[Medline]
  57. Mattner, F., K. Di Padova, G. Alber. 1997. Interleukin-12 is indispensable for protective immunity against Leishmania major. Infect. Immun. 65:4378.[Abstract]
  58. Mattner, F., J. Magram, J. Ferrante, P. Launois, K. Di Padova, R. Behin, M. K. Gately, J. A. Louis, G. Alber. 1996. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. Eur. J. Immunol. 26:1553.[Medline]



This article has been cited by other articles:


Home page
JEMHome page
S. F. Martin, J. C. Dudda, E. Bachtanian, A. Lembo, S. Liller, C. Durr, M. M. Heimesaat, S. Bereswill, G. Fejer, R. Vassileva, et al.
Toll-like receptor and IL-12 signaling control susceptibility to contact hypersensitivity
J. Exp. Med., September 1, 2008; 205(9): 2151 - 2162.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Uematsu, T. Kaisho, T. Tanaka, M. Matsumoto, M. Yamakami, H. Omori, M. Yamamoto, T. Yoshimori, and S. Akira
The C/EBPbeta Isoform 34-kDa LAP Is Responsible for NF-IL-6-Mediated Gene Induction in Activated Macrophages, but Is Not Essential for Intracellular Bacteria Killing
J. Immunol., October 15, 2007; 179(8): 5378 - 5386.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Liu, Y. Yang, J. Dai, R. Medzhitov, M. A. Freudenberg, P. L. Zhang, and Z. Li
TLR4 Up-Regulation at Protein or Gene Level Is Pathogenic for Lupus-Like Autoimmune Disease
J. Immunol., November 15, 2006; 177(10): 6880 - 6888.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
T. Ohteki, H. Tada, K. Ishida, T. Sato, C. Maki, T. Yamada, J. Hamuro, and S. Koyasu
Essential roles of DC-derived IL-15 as a mediator of inflammatory responses in vivo
J. Exp. Med., October 2, 2006; 203(10): 2329 - 2338.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Yeramian, L. Martin, N. Serrat, L. Arpa, C. Soler, J. Bertran, C. McLeod, M. Palacin, M. Modolell, J. Lloberas, et al.
Arginine Transport via Cationic Amino Acid Transporter 2 Plays a Critical Regulatory Role in Classical or Alternative Activation of Macrophages
J. Immunol., May 15, 2006; 176(10): 5918 - 5924.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A.-C. Oliveira, J. R. Peixoto, L. B. de Arruda, M. A. Campos, R. T. Gazzinelli, D. T. Golenbock, S. Akira, J. O. Previato, L. Mendonca-Previato, A. Nobrega, et al.
Expression of Functional TLR4 Confers Proinflammatory Responsiveness to Trypanosoma cruzi Glycoinositolphospholipids and Higher Resistance to Infection with T. cruzi
J. Immunol., November 1, 2004; 173(9): 5688 - 5696.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Marques, M. Brucet, J. Lloberas, and A. Celada
STAT1 Regulates Lipopolysaccharide- and TNF-{alpha}-Dependent Expression of Transporter Associated with Antigen Processing 1 and Low Molecular Mass Polypeptide 2 Genes in Macrophages by Distinct Mechanisms
J. Immunol., July 15, 2004; 173(2): 1103 - 1110.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
P. Kropf, N. Freudenberg, C. Kalis, M. Modolell, S. Herath, C. Galanos, M. Freudenberg, and I. Muller
Infection of C57BL/10ScCr and C57BL/10ScNCr mice with Leishmania major reveals a role for Toll-like receptor 4 in the control of parasite replication
J. Leukoc. Biol., July 1, 2004; 76(1): 48 - 57.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
P. Kropf, M. A. Freudenberg, M. Modolell, H. P. Price, S. Herath, S. Antoniazi, C. Galanos, D. F. Smith, and I. Muller
Toll-Like Receptor 4 Contributes to Efficient Control of Infection with the Protozoan Parasite Leishmania major
Infect. Immun., April 1, 2004; 72(4): 1920 - 1928.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
M. Comalada, J. Xaus, A. F. Valledor, C. Lopez-Lopez, D. J. Pennington, and A. Celada
PKC{epsilon} is involved in JNK activation that mediates LPS-induced TNF-{alpha}, which induces apoptosis in macrophages
Am J Physiol Cell Physiol, November 1, 2003; 285(5): C1235 - C1245.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
M. A. Freudenberg, C. Kalis, Y. Chvatchko, T. Merlin, M. Gumenscheimer, and C. Galanos
Role of interferons in LPS hypersensitivity
Innate Immunity, October 1, 2003; 9(5): 308 - 312.
[Abstract] [PDF]


Home page
Infect. Immun.Home page
A. Lembo, C. Kalis, C. J. Kirschning, V. Mitolo, E. Jirillo, H. Wagner, C. Galanos, and M. A. Freudenberg
Differential Contribution of Toll-Like Receptors 4 and 2 to the Cytokine Response to Salmonella enterica Serovar Typhimurium and Staphylococcus aureus in Mice
Infect. Immun., October 1, 2003; 71(10): 6058 - 6062.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
U. Deiters, M. Gumenscheimer, C. Galanos, and P. F. Muhlradt
Toll-Like Receptor 2- and 6-Mediated Stimulation by Macrophage-Activating Lipopeptide 2 Induces Lipopolysaccharide (LPS) Cross Tolerance in Mice, Which Results in Protection from Tumor Necrosis Factor Alpha but in Only Partial Protection from Lethal LPS Doses
Infect. Immun., August 1, 2003; 71(8): 4456 - 4462.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. Bihl, L. Salez, M. Beaubier, D. Torres, L. Lariviere, L. Laroche, A. Benedetto, D. Martel, J.-M. Lapointe, B. Ryffel, et al.
Overexpression of Toll-Like Receptor 4 Amplifies the Host Response to Lipopolysaccharide and Provides a Survival Advantage in Transgenic Mice
J. Immunol., June 15, 2003; 170(12): 6141 - 6150.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
E. Jirillo, D. Caccavo, T. Magrone, E. Piccigallo, L. Amati, A. Lembo, C. Kalis, and M. Gumenscheimer
Review: The role of the liver in the response to LPS: experimental and clinical findings
Innate Immunity, October 1, 2002; 8(5): 319 - 327.
[Abstract] [PDF]


Home page
Innate ImmunityHome page
B. Beutler
Review paper: LPS in microbial pathogenesis: promise and fulfilment
Innate Immunity, October 1, 2002; 8(5): 329 - 335.
[Abstract] [PDF]


Home page
J. Immunol.Home page
M. A. Freudenberg, T. Merlin, C. Kalis, Y. Chvatchko, H. Stubig, and C. Galanos
Cutting Edge: A Murine, IL-12-Independent Pathway of IFN-{gamma} Induction by Gram-Negative Bacteria Based on STAT4 Activation by Type I IFN and IL-18 Signaling
J. Immunol., August 15, 2002; 169(4): 1665 - 1668.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
R. R. Ganta, M. J. Wilkerson, C. Cheng, A. M. Rokey, and S. K. Chapes
Persistent Ehrlichia chaffeensis Infection Occurs in the Absence of Functional Major Histocompatibility Complex Class II Genes
Infect. Immun., January 1, 2002; 70(1): 380 - 388.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
L. M. Haynes, D. D. Moore, E. A. Kurt-Jones, R. W. Finberg, L. J. Anderson, and R. A. Tripp
Involvement of Toll-Like Receptor 4 in Innate Immunity to Respiratory Syncytial Virus
J. Virol., November 15, 2001; 75(22): 10730 - 10737.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
E. Lorenz, M. Jones, C. Wohlford-Lenane, N. Meyer, K. L. Frees, N. C. Arbour, and D. A. Schwartz
Genes other than TLR4 are involved in the response to inhaled LPS
Am J Physiol Lung Cell Mol Physiol, November 1, 2001; 281(5): L1106 - L1114.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Poltorak, T. Merlin, P. J. Nielsen, O. Sandra, I. Smirnova, I. Schupp, T. Boehm, C. Galanos, and M. A. Freudenberg
A Point Mutation in the IL-12R{beta}2 Gene Underlies the IL-12 Unresponsiveness of Lps-Defective C57BL/10ScCr Mice
J. Immunol., August 15, 2001; 167(4): 2106 - 2111.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
T. Merlin, M. Gumenscheimer, C. Galanos, and M. A. Freudenberg
TNF-{alpha} hyper-responses to Gram-negative and Gram-positive bacteria in Propionibacterium acnes primed or Salmonella typhimurium infected mice
Innate Immunity, April 1, 2001; 7(2): 157 - 163.
[Abstract] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Merlin, T.
Right arrow Articles by Freudenberg, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Merlin, T.
Right arrow Articles by Freudenberg, M. A.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS